| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.440.715 | 7.365.996 | 5.241.524 | 5.174.022 | 4.886.810 | 4.167.953 | 5.006.748 | 6.024.392 | 6.068.909 | 5.492.464 |
| Total Income - EUR | 3.903.862 | 3.494.619 | 1.555.649 | 2.085.513 | 2.247.615 | 1.011.444 | 1.639.424 | 8.045.794 | 6.660.501 | 5.275.445 |
| Total Expenses - EUR | 3.866.022 | 3.478.105 | 1.475.986 | 1.972.507 | 4.374.401 | 894.399 | 1.475.408 | 7.848.261 | 6.526.722 | 5.130.702 |
| Gross Profit/Loss - EUR | 37.840 | 16.514 | 79.663 | 113.006 | -2.126.786 | 117.045 | 164.016 | 197.534 | 133.780 | 144.743 |
| Net Profit/Loss - EUR | 29.673 | 11.628 | 32.279 | 96.405 | -2.131.513 | 98.318 | 139.183 | 166.456 | 111.496 | 122.742 |
| Employees | 44 | 67 | 52 | 44 | 36 | 20 | 31 | 37 | 32 | 21 |
Check the financial reports for the company - Picofarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.493.289 | 1.433.089 | 1.383.132 | 1.309.741 | 1.245.646 | 3.244.511 | 3.148.218 | 3.120.488 | 3.073.514 | 3.025.894 |
| Current Assets | 6.761.715 | 6.299.986 | 7.580.167 | 7.860.609 | 4.280.199 | 4.671.972 | 4.673.542 | 5.336.615 | 6.525.264 | 6.426.624 |
| Inventories | 1.678.927 | 2.281.229 | 3.061.012 | 3.347.314 | 314.590 | 626.144 | 947.557 | 1.600.766 | 2.418.644 | 2.600.802 |
| Receivables | 3.145.435 | 3.497.724 | 3.730.860 | 3.643.320 | 3.542.078 | 3.315.320 | 3.580.111 | 3.617.811 | 3.603.331 | 3.663.474 |
| Cash | 1.937.352 | 521.034 | 788.295 | 869.975 | 423.531 | 730.508 | 145.874 | 118.038 | 503.289 | 162.348 |
| Shareholders Funds | -54.530 | -42.256 | 1.193 | 97.527 | -2.035.874 | 176.181 | 645.422 | 813.881 | 922.909 | 1.040.493 |
| Social Capital | 10.349 | 10.243 | 10.070 | 9.885 | 9.694 | 56.356 | 389.001 | 390.208 | 389.025 | 386.850 |
| Debts | 8.309.533 | 7.775.331 | 8.962.106 | 9.072.823 | 7.561.720 | 7.740.301 | 7.176.337 | 7.643.222 | 8.675.869 | 8.412.025 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
146
|
|||||||||
Comments - Picofarm Srl